ChristianaCare Spins Out CorriXR Therapeutics, New Gene Editing Start-Up

Oct 14, 2022

3 min

Eric Kmiec, Ph.D

Commercial biotechnology venture will harness the power of gene editing to revolutionize patient care with faster, more accurate diagnoses


ChristianaCare today announced it has spun out its first commercial biotechnology private start-up company, named CorriXR Therapeutics.



CorriXR Therapeutics (pronounced Cor-ix-er; from Galician meaning to correct or edit) will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung. Its close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions it to research and develop innovative, patient-centered therapies.


The new start-up company has been boosted with $5 million in seed financing from ChristianaCare and Brookhaven Bio.


“We are excited to spin out CorriXR Therapeutics, which has an enormous opportunity to use the incredible power of gene editing to revolutionize patient care by delivering faster and more accurate diagnoses, targeting treatments and preventing genetic disorders,” said Janice Nevin, M.D., MPH, ChristianaCare president and CEO.


The company has developed unique CRISPR/Cas biomolecular tools that disable the genome of a tumor cell but not the genome of a healthy cell, which enables target selectivity.


CorriXR Therapeutics will license technology from the Gene Editing Institute and work closely with its scientific researchers and clinical oncologists at the Helen F. Graham Cancer Center & Research Institute. The Gene Editing Institute’s integrated bench-to-bedside approach connects leading-edge science to patient care.


“CorriXR Therapeutics is the next phase of the Gene Editing Institute’s evolution and impact as an incubator for groundbreaking technology in a patient-first approach to research,” said Eric Kmiec, Ph.D., chief executive officer of CorriXR Therapeutics.


“The novel way we are using CRISPR-directed gene editing technology in solid tumors, beginning with a hard-to-treat form of lung cancer, has enormous promise as a treatment option to improve the lives of people with life-threatening disease.”


The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D., chief executive officer, and Brian Longstreet, chief operating officer.


Kmiec is also the executive director and chief scientific officer of ChristianaCare’s Gene Editing Institute. He is widely recognized for his pioneering work in the fields of molecular medicine and gene editing, having discovered many of the molecular activities that regulate the efficiency of human gene editing.


Longstreet, a graduate of the University of Pennsylvania’s Wharton School of Business, is a seasoned pharma and biotechnology industry veteran with over 30 years’ experience, beginning at Schering-Plough and then Merck & Co. Recently, he has helped to build start-up biotechnology companies.


Earlier this year, ChristianaCare restructured its Gene Editing Institute into a wholly owned subsidiary, which positions it to advance research to develop therapies using CRISPR gene editing technology and to fast-track discoveries for commercial application. The new structure also enables it to expand its educational outreach using its CRISPR in a Box™ educational toolkit and to develop its analytic software program, DECODR™. The Gene Editing Institute originated in ChristianaCare’s Helen F. Graham Cancer Center & Research Institute in 2015.



Connect with:
Eric Kmiec, Ph.D

Eric Kmiec, Ph.D

Executive Director and Chief Scientific Officer, The Gene Editing Institute

Dr. Kmiec, a pioneer in the field, has achieved several ground-breaking firsts in CRISPR gene editing.

Gene EditingBiomedical ResearchMolecular Medicine

You might also like...

Check out some other posts from ChristianaCare

3 min

ChristianaCare Reduces Health Care Costs by $6.2 Million While Improving Care for Medicaid Patients

ChristianaCare’s Delaware Medicaid Partners Accountable Care Organization (ACO) has set the standard for innovative, high-quality care at lower cost for the State of Delaware’s Medicaid population. According to the most recent data available, ChristianaCare’s ACO reduced health care spending by $6.2 million in 2023 while improving care for nearly 30,000 Medicaid beneficiaries in Delaware, including approximately 8,000 children. “We’re demonstrating that population health works,” said Christine Donohue-Henry, M.D., MBA, chief population health officer, ChristianaCare. “Our neighbors count on us to take care of them — and we can improve their health while also helping the state reduce health care costs. We do this by delivering high-quality care that emphasizes preventive care and proactive management of health conditions, and by investing in our population health infrastructure. “In this way, we can keep people healthier and reduce the need for them to access the most expensive kinds of care, such as emergency care and hospitalization.” ChristianaCare’s Medicaid ACO includes more than 1,900 primary and specialty care clinicians who partner with patients and families to prevent illness, manage chronic diseases and help them achieve their health goals. The ACO makes it easy for adults and children to get the screenings and treatments they need, improving overall health. ChristianaCare’s Medicaid ACO is one of four authorized by the State of Delaware and the only one to voluntarily accept downside financial risk at its launch in 2021, which means that if ChristianaCare’s Medicaid ACO is not successful in reducing cost and improving care for a particular year, the ChristianaCare ACO is required to make a payment to the state. By sharing in both savings and losses, the ACO controls state health care costs while maintaining high-quality care. Bending the Cost Curve by Focusing on High-Quality Preventive Care Alongside financial savings, ChristianaCare’s Medicaid ACO has improved care quality and worked to reduce health disparities. By focusing on preventive care, the ACO has helped adults and children get the screenings and treatment they need, leading to better health outcomes and fewer unmet needs. Since launching in 2021, ChristianaCare’s ACO has met all required quality standards and consistently improved its performance each year on key measures like diabetes management, blood pressure control and breast cancer prevention. Year over year, breast cancer screenings have increased by 4%, while patients with high blood pressure (hypertension) have shown improvement in blood pressure control. Notably, healthy blood sugar levels (HbA1c less than 8%) have also improved in patients with diabetes by 7%. In collaboration with its Medicaid health plan partners, ChristianaCare primary care and imaging teams host patient-centered health and wellness day events to increase access to care, close quality gaps and improve the overall health of the communities they serve. These events help patients get preventive screenings and services, supporting the ACO’s goals of better care and health equity. The ACO’s success is driven by its focus on caring for entire families, including addressing the needs of pregnant mothers and supporting children and adults throughout their lives, according to Rose Kakoza, M.D., MPH, senior clinical network director, ChristianaCare Clinical Alliance. Key programs include enhanced maternity care to support mothers and infants, expanded mental health services and social support programs that address food and housing needs. By integrating clinical care with social support — such as help with food and housing — the ACO is working to break cycles of poor health across generations. This approach also has practical benefits. For example, the improved mental health of a parent strengthens the family environment, supporting children’s well-being and development. “By making significant investments in population health and addressing both medical needs and the social drivers of health, we’ve not only improved health outcomes but also more effectively managed costs for Delaware’s most vulnerable residents, helping to reduce state spending,” Kakoza said. About Delaware Medicaid Partners Delaware Medicaid Partners ACO, led by ChristianaCare, uses a family-centered approach to save money and improve care for Medicaid patients. By combining medical care with social support, the ACO addresses the unique needs of Medicaid patients, improving health and promoting equity. Care coordination is provided by ChristianaCare’s CareVio®, whose team of nurses, social workers, and pharmacists help patients with serious health conditions get the care they need. CareVio uses real-time data to prevent complications that could lead to unnecessary hospital stays or emergency visits. Through ongoing collaboration and innovation, Delaware Medicaid Partners ACO aims to set an example for other states working to improve care while managing costs.

2 min

Nona’s Story: HomeHealth Nurse Visit Leads to Life-Saving Care

Elena Gomez, RN, wears the dark blue scrubs of a ChristianaCare nurse, but Nona Lerza sees her as even more. “I call you an angel,” said Lerza, who credits Gomez with saving her life. Gomez, a ChristianaCare HomeHealth case manager, regularly visited Lerza, at her home in Middletown, Delaware, to check her blood pressure after a hospitalization. One day in February, with bad weather on the horizon, Gomez phoned Lerza to see if she could stop by for a check-in. That call – and Gomez’s persistence – turned out to be lifesaving. During her visit, Gomez found Lerza’s blood pressure was high – high enough to warrant emergency care. Lerza wasn’t eager to return to the hospital. But she trusted Gomez, and the strength of that connection convinced Lerza to heed Gomez’s advice and head to the emergency department. After arriving by ambulance, Lerza underwent quadruple bypass surgery at Christiana Hospital. Her cardiology team agreed – Gomez saved her life. Fully recovered, Lerza is now back to living independently in her home. “There aren’t enough words in the dictionary to say all she did for me,” Lerza said. “She closed my house up. She did everything for me that night and I can’t thank her enough. It seems very hollow to say thank you. But if she hadn’t come, I don’t know where I’d be today.” For Gomez – a second generation nurse – working as a HomeHealth nurse gives her the chance to build lasting relationships with patients. “We are here for the community; we are here for our patients; we are here for the families,” she said, “and we will do everything in our power to help them get better.”

2 min

ChristianaCare Caregivers Help Our Neighbors on Martin Luther King Jr. Day of Service

More than 200 ChristianaCare caregivers and their families came together for a systemwide service project on the Martin Luther King Jr. Day of Service on Jan. 20 to pack supply kits for neighbors in need. Hosted by ChristianaCare’s Office of Inclusion & Diversity, caregivers united in service on our Cecil County, Newark and Wilmington campuses.  These volunteers assembled 3,500 supply kits with essential items like washcloths, dish soap and detergent for individuals transitioning into permanent housing and toiletries, journals and puzzle books for patients in treatment for cancer at the Helen F. Graham Cancer Center & Research Institute. The kits also carried inspiration. Caregivers handwrote encouraging messages that were tucked in alongside toiletries and other essentials: “You’ve got this!” “You are stronger than you know.” “This is tough. But so are you!” Other caregivers delivered the inspirations and the kits to the the Graham Cancer Center, the Union Hospital Emergency Department, New Castle County Hope Center, Inc., and other community partners. Natalie Torres, director of Inclusion & Diversity, credited ChristianaCare’s Supply Chain and Transportation departments with making sure toiletries and other supplies were available at the three campus locations and also coordinating the pickup and delivery of donations. “This service project is such a powerful reminder of how our values of love and excellence shine through in everything that we do,” Torres said. “Dr. King truly resonates with who we are as an organization. Serving our community, connecting with one another, making a difference — it’s what we do best — and we are so honored to carry on this tradition in Dr. King’s name.”

View all posts